The synaptic Abeta hypothesis of Alzheimer disease - PubMed (original) (raw)
Comment
The synaptic Abeta hypothesis of Alzheimer disease
Rudolph E Tanzi. Nat Neurosci. 2005 Aug.
No abstract available
Comment on
- Regulation of NMDA receptor trafficking by amyloid-beta.
Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P. Snyder EM, et al. Nat Neurosci. 2005 Aug;8(8):1051-8. doi: 10.1038/nn1503. Epub 2005 Jul 17. Nat Neurosci. 2005. PMID: 16025111
Similar articles
- Amyloid beta peptides and glutamatergic synaptic dysregulation.
Parameshwaran K, Dhanasekaran M, Suppiramaniam V. Parameshwaran K, et al. Exp Neurol. 2008 Mar;210(1):7-13. doi: 10.1016/j.expneurol.2007.10.008. Epub 2007 Oct 24. Exp Neurol. 2008. PMID: 18053990 Review. - Alzheimer's disease and Abeta toxicity: from top to bottom.
Small DH, Mok SS, Bornstein JC. Small DH, et al. Nat Rev Neurosci. 2001 Aug;2(8):595-8. doi: 10.1038/35086072. Nat Rev Neurosci. 2001. PMID: 11484003 Review. No abstract available. - epsilon-Glycation, APP and Abeta in ageing and Alzheimer disease: a hypothesis.
Schmitt HP. Schmitt HP. Med Hypotheses. 2006;66(5):898-906. doi: 10.1016/j.mehy.2005.11.016. Epub 2006 Jan 27. Med Hypotheses. 2006. PMID: 16442744 - Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
Shemer I, Holmgren C, Min R, Fülöp L, Zilberter M, Sousa KM, Farkas T, Härtig W, Penke B, Burnashev N, Tanila H, Zilberter Y, Harkany T. Shemer I, et al. Eur J Neurosci. 2006 Apr;23(8):2035-47. doi: 10.1111/j.1460-9568.2006.04733.x. Eur J Neurosci. 2006. PMID: 16630051 - Intracellular amyloid-beta in Alzheimer's disease.
LaFerla FM, Green KN, Oddo S. LaFerla FM, et al. Nat Rev Neurosci. 2007 Jul;8(7):499-509. doi: 10.1038/nrn2168. Nat Rev Neurosci. 2007. PMID: 17551515 Review.
Cited by
- NMDA Receptors: Distribution, Role, and Insights into Neuropsychiatric Disorders.
Beaurain M, Salabert AS, Payoux P, Gras E, Talmont F. Beaurain M, et al. Pharmaceuticals (Basel). 2024 Sep 25;17(10):1265. doi: 10.3390/ph17101265. Pharmaceuticals (Basel). 2024. PMID: 39458906 Free PMC article. Review. - Salivary Alpha-amylase Activity and Mild Cognitive Impairment Among Japanese Older Adults: The Toon Health Study.
Yamane N, Ikeda AI, Tomooka K, Saito I, Maruyama K, Eguchi E, Suyama K, Fujii A, Shiba T, Tanaka K, Kooka A, Nakamura S, Kajita M, Kawamura R, Takata Y, Osawa H, Steptoe A, Tanigawa T. Yamane N, et al. Juntendo Iji Zasshi. 2023 Jun 22;69(3):194-196. doi: 10.14789/jmj.JMJ23-0013-OT. eCollection 2023. Juntendo Iji Zasshi. 2023. PMID: 38855948 Free PMC article. No abstract available. - A Nanoenzyme Constructed from Manganese and Strandberg-Type Phosphomolybdate with Versatility in Antioxidant and Modulating Conformation of A_β_ Protein Misfolding Aggregates In Vitro.
Hua J, Wang F, Wei X, Qin Y, Lian J, Wu J, Ma P, Ma X. Hua J, et al. Int J Mol Sci. 2023 Feb 21;24(5):4317. doi: 10.3390/ijms24054317. Int J Mol Sci. 2023. PMID: 36901748 Free PMC article. - Positron Emission Tomography in Animal Models of Alzheimer's Disease Amyloidosis: Translational Implications.
Ni R. Ni R. Pharmaceuticals (Basel). 2021 Nov 18;14(11):1179. doi: 10.3390/ph14111179. Pharmaceuticals (Basel). 2021. PMID: 34832961 Free PMC article. Review. - Integrative analysis of key candidate genes and signaling pathways in acute coronary syndrome related to obstructive sleep apnea by bioinformatics.
Shi Y, Jiang Z, Jiang L, Xu J. Shi Y, et al. Sci Rep. 2021 Jul 8;11(1):14153. doi: 10.1038/s41598-021-93789-2. Sci Rep. 2021. PMID: 34239024 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical